KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Free Cash Flow: 2009-2025

Historic Free Cash Flow for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $178.2 million.

  • Charles River Laboratories International's Free Cash Flow fell 16.34% to $178.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $543.7 million, marking a year-over-year decrease of 3.00%. This contributed to the annual value of $501.6 million for FY2024, which is 37.29% up from last year.
  • Charles River Laboratories International's Free Cash Flow amounted to $178.2 million in Q3 2025, which was up 5.28% from $169.3 million recorded in Q2 2025.
  • Charles River Laboratories International's 5-year Free Cash Flow high stood at $213.1 million for Q3 2024, and its period low was $2.5 million during Q2 2023.
  • In the last 3 years, Charles River Laboratories International's Free Cash Flow had a median value of $139.5 million in 2023 and averaged $120.6 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 88.69% in 2023, then surged by 1,923.29% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Free Cash Flow stood at $130.5 million in 2021, then rose by 11.69% to $145.7 million in 2022, then declined by 2.14% to $142.6 million in 2023, then tumbled by 41.28% to $83.7 million in 2024, then fell by 16.34% to $178.2 million in 2025.
  • Its Free Cash Flow stands at $178.2 million for Q3 2025, versus $169.3 million for Q2 2025 and $112.4 million for Q1 2025.